Thompson Dean serves as Executive at Organogenesis Holdings Inc., where they oversee executive responsibilities. Since joining the company, Thompson Dean has executed 6 insider transactions totaling $14.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 19, 2020 involved purchasing 36,127 shares valued at $179.6K.
Thompson Dean currently holds 29,921,676 shares of Organogenesis Holdings Inc. (ORGO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thompson Dean has been a net buyer of ORGO stock. They have purchased $14.5M and sold $0 worth of shares.
Thompson Dean's most recent insider trade was on Nov 19, 2020, when they purchased 36,127 shares at $4.97 per share.
Get notified when new Form 4 filings are submitted
| $4.68 |
| Discretionary |
| Nov 17, 2020 | ORGO | $13.9M | Purchase | 4,272,657 | $3.25 | Discretionary |
| Nov 17, 2020 | ORGO | $222.5K | Purchase | 50,000 | $4.45 | Discretionary |
| Dec 10, 2018 | ORGO | $0 | Award | 6,538,732 | $N/A | Discretionary |
| Dec 10, 2018 | ORGO | $0 | Award | 9,022,741 | $N/A | Discretionary |